Dr Sofia Bartlett

Kronfli N; Dussault C; Bartlett S; Fuchs D; Kaita K; Harland K; Martin B; Whitten-Nagle C; Cox J, 2021, 'Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination', CANADIAN LIVER JOURNAL, vol. 4, pp. 292 - 310, http://dx.doi.org/10.3138/canlivj-2020-0035

Gin S; Buxton J; Janjua NZ; Krajden M; Bartlett SR, 2021, 'Addressing inequities in care on the path to eliminating hepatitis C in BC', British Columbia Medical Journal, vol. 63, pp. 252

Bartlett SR; Wong S; Yu A; Pearce M; MacIsaac J; Nouch S; Adu P; Wilton J; Samji H; Clementi E; Velasquez H; Jeong D; Binka M; Alvarez M; Wong J; Buxton J; Krajden M; Janjua NZ, 2021, 'The impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from in the DAA era: A population-based study.', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciab546

Jeong D; Karim ME; Wong S; Wilton J; Butt ZA; Binka M; Adu PA; Bartlett S; Pearce M; Clementi E; Yu A; Alvarez M; Samji H; Velásquez García HA; Abdia Y; Krajden M; Janjua NZ, 2021, 'Impact of HCV infection and ethnicity on incident type 2 diabetes: Findings from a large population-based cohort in British Columbia', BMJ Open Diabetes Research and Care, vol. 9, http://dx.doi.org/10.1136/bmjdrc-2021-002145

Adu PA; Rossi C; Binka M; Wong S; Wilton J; Wong J; Butt ZA; Bartlett S; Jeong D; Pearce M; Darvishian M; Yu A; Alvarez M; Velásquez García HA; Krajden M; Janjua NZ, 2021, 'HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men', Liver International, vol. 41, pp. 482 - 493, http://dx.doi.org/10.1111/liv.14762

Bartlett SR; Buxton J; Palayew A; Picchio CA; Janjua NZ; Kronfli N, 2021, 'Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct-Acting Antiviral Era', Clinical Liver Disease, vol. 17, pp. 75 - 80, http://dx.doi.org/10.1002/cld.1023

Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M, 2021, '"The Times They Are a-Changin'": Addressing Common Misconceptions About the Role of Safe Supply in North America's Overdose Crisis', Journal of studies on alcohol and drugs, vol. 82, pp. 158 - 160, http://dx.doi.org/10.15288/jsad.2021.82.158

Samji H; Yu A; Wong S; Wilton J; Binka M; Alvarez M; Bartlett S; Pearce M; Adu P; Jeong D; Clementi E; Butt Z; Buxton J; Gilbert M; Krajden M; Janjua NZ, 2020, 'Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada', International Journal of Drug Policy, vol. 86, http://dx.doi.org/10.1016/j.drugpo.2020.102989

Pearce ME; Yu A; Alvarez M; Bartlett SR; Binka M; Jeong D; Clementi E; Adu P; Wilton J; Yoshida EM; Pick N; Buxton JA; Wong J; Jassem A; Krajden M; Janjua NZ, 2020, 'Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019', PLoS ONE, vol. 15, http://dx.doi.org/10.1371/journal.pone.0244575

Clementi E; Bartlett S; Otterstatter M; Buxton JA; Wong S; Yu A; Butt ZA; Wilton J; Pearce M; Jeong D; Binka M; Adu P; Alvarez M; Samji H; Abdia Y; Wong J; Krajden M; Janjua NZ, 2020, 'Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services', International Journal of Infectious Diseases, vol. 100, pp. 27 - 33, http://dx.doi.org/10.1016/j.ijid.2020.08.035

Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, vol. 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985

Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M, 2020, 'Addressing the syndemic of hiv, hepatitis c, overdose, and covid-19 among people who use drugs: The potential roles for decriminalization and safe supply', Journal of Studies on Alcohol and Drugs, vol. 81, pp. 556 - 560, http://dx.doi.org/10.15288/jsad.2020.81.556

Wilton J; Wong S; Yu A; Ramji A; Cook D; Butt ZA; Alvarez M; Binka M; Darvishian M; Jeong D; Bartlett SR; Pearce ME; Adu PA; Yoshida EM; Krajden M; Janjua NZ, 2020, 'Real-world effectiveness of sofosbuvir/velpatasvir for treatment of chronic Hepatitis C in British Columbia, Canada: A population-based cohort study', Open Forum Infectious Diseases, vol. 7, http://dx.doi.org/10.1093/ofid/ofaa055

Darvishian M; Wong S; Binka M; Yu A; Ramji A; Yoshida EM; Wong J; Rossi C; Butt ZA; Bartlett S; Pearce ME; Samji H; Cook D; Alvarez M; Chong M; Tyndall M; Krajden M; Janjua NZ, 2020, 'Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies', Journal of Viral Hepatitis, vol. 27, pp. 243 - 260, http://dx.doi.org/10.1111/jvh.13228

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, vol. 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Janjua N; Wilton J; Cook D; Wong S; Butt Z; Bartlett S; Pearce DM; Ramji A; Yoshida E; Yu A; Alvarez M; Binka M; Krajden M, 2020, 'Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment', Journal of Hepatology, vol. 73, pp. S356 - S357, http://dx.doi.org/10.1016/s0168-8278(20)31209-5

Janjua N; Yu A; Wilton J; Adu P; Pearce DM; Samji H; McKee G; Bartlett S; Butt Z; Binka M; Abdia Y; Wong S; Jeong D; Clementi E; Alvarez M; Wong DJ; Krajden M, 2020, 'Population-level hepatitis C cascade of care among men who have sex with men in British Columbia, Canada', Journal of Hepatology, vol. 73, pp. S32 - S32, http://dx.doi.org/10.1016/s0168-8278(20)30617-6

Binka M; Abdia Y; Wilton J; Butt Z; Darvishian M; Wong S; Yu A; Bartlett S; Jeong D; Clementi E; Adu P; Pearce DM; Alvarez M; Yoshida E; Ramji A; Wong DJ; Krajden M; Janjua N, 2020, 'All-cause mortality and liver-related death following entecavir, tenofovir disoproxil fumarate or lamivudine therapy among treatment-naive chronic hepatitis B patients in British Columbia, Canada', Journal of Hepatology, vol. 73, pp. S875 - S876, http://dx.doi.org/10.1016/s0168-8278(20)32192-9

Clementi E; Bartlett S; Janjua N; Wong S; Yu A; Pearce DM; Binka M; Alvarez M; Jeong D; Wilton J; Adu P; Abdia Y; Wong DJ; Krajden M; Buxton J; Otterstatter M; Butt Z; McKee G, 2020, 'Classifying people living with hepatitis C virus using a population-level latent class analysis to inform optimal integration of health services', Journal of Hepatology, vol. 73, pp. S804 - S805, http://dx.doi.org/10.1016/s0168-8278(20)32053-5

Pearce DM; Yu A; Alvarez M; Bartlett S; Binka M; Jeong D; Clementi E; Jassem A; Yoshida E; Wong DJ; Pick N; Krajden M; Janjua N, 2020, 'Frequency of prenatal hepatitis C screening and diagnosis in British Columbia, 2008–2018', Journal of Hepatology, vol. 73, pp. S814 - S815, http://dx.doi.org/10.1016/s0168-8278(20)32071-7

Jeong D; Wong S; Karim ME; Binka M; Butt Z; Abdia Y; Adu P; Wilton J; Yu A; Alvarez M; Pearce DM; Bartlett S; Krajden M; Janjua N, 2020, 'Ethnic disparities in the risk of hepatitis C virus-related diabetes in a large population-based cohort in Canada', Journal of Hepatology, vol. 73, pp. S309 - S309, http://dx.doi.org/10.1016/s0168-8278(20)31120-x

Janjua N; Wong S; Wilton J; Adu P; Butt Z; Samji H; McKee G; Binka M; Abdia Y; Yu A; Bartlett S; Jeong D; Clementi E; Pearce DM; Alvarez M; Wong DJ; Krajden M, 2020, 'Incidence of HCV infection among gbMSM in British Columbia, Canada: a population-based cohort study', Journal of Hepatology, vol. 73, pp. S819 - S819, http://dx.doi.org/10.1016/s0168-8278(20)32080-8

Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ, 2019, 'The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals', Liver International, vol. 39, pp. 2261 - 2272, http://dx.doi.org/10.1111/liv.14227

Rossi C; Jeong D; Wong S; McKee G; Butt ZA; Buxton J; Wong J; Darvishian M; Bartlett S; Samji H; Yu A; Binka M; Alvarez M; Adu PA; Tyndall M; Krajden M; Janjua NZ, 2019, 'Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations', Journal of Hepatology, vol. 71, pp. 1116 - 1125, http://dx.doi.org/10.1016/j.jhep.2019.07.021

Bartlett S; Krajden M; Janjua N; Buller-Taylor T, 2019, 'Using population-level integrated health data to monitor and assess patients’ progression across care and treatment continuums', British Columbia Medical Journal, vol. 61, pp. 78 - 80

Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, vol. 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222

Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, vol. 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9

Janjua N; Wong S; Rossi C; Darvishian M; Yu A; Butt ZA; Yoshida E; Ramji A; Feld J; Binka M; Bartlett S; Pearce DM; Alvarez M; Samji H; Tyndall M; Krajden M, 2019, 'SAT-238-The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk in a large population based cohort', Journal of Hepatology, vol. 70, pp. e736 - e736, http://dx.doi.org/10.1016/s0618-8278(19)31471-9

Bartlett SR; Fox P; Cabatingan H; Jaros A; Gorton C; Lewis R; Priscott E; Dore GJ; Russell DB, 2018, 'Demonstration of near-elimination of Hepatitis C virus among a prison population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project', Clinical Infectious Diseases, vol. 67, pp. 460 - 463, http://dx.doi.org/10.1093/cid/ciy210

Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, vol. 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652

Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky JM; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review', Hepatology Communications, vol. 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050

Martinello M; Dore GJ; Bopage RI; Finlayson R; Baker D; Bloch M; Filep E; Skurowski J; Lin L; Lamoury F; Bartlett S; Applegate T; Hellard M; Matthews GV, 2017, 'O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy', Journal of Virus Eradication, vol. 3, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30890-6

Bartlett SR; Applegate T; Jacka B; Lamoury F; Bull R; Danta M; Bradshaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2017, 'P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015', Journal of Virus Eradication, vol. 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30747-0

Russell DB; Fox P; Cabatingan H; Jaros A; Gorton C; Lewis R; Priscott E; Bartlett S; Dore GJ, 2017, 'O16 A regional prison cleared of hepatitis C in less than 12 months', Journal of Virus Eradication, vol. 3, pp. 6 - 6, http://dx.doi.org/10.1016/s2055-6640(20)30899-2

Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, vol. 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028

Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131437

Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, vol. 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003

Bartlett SR; Seeliger J; Burnell JN, 2012, 'Identification of critical residues in the bifunctional phosphoenolpyruvate synthetase kinase/phosphotransferase of Escherichia coli', Current Topics in Biochemical Research, vol. 14, pp. 77 - 83

Janjua N; Wong S; Bartlett S; Adu P; Butt ZA; Wong J; Pearce M; Yu A; Samji H; Rossi C; Alvarez MJ; Binka M; Krajden M, 2019, 'HEPATITIS C VIRUS REINFECTION AFTER SUCCESSFUL TREATMENT WITH DIRECT-ACTING ANTIVIRAL THERAPY AMONG MSM', in HEPATOLOGY, WILEY, Boston, MA, pp. 961A - 962A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA, 08 November 2019 - 12 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653503283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Janjua N; Wong S; Bartlett S; Butt ZA; Wong J; Adu P; Samji H; Yu A; Pearce M; Alvarez MJ; Binka M; Krajden M, 2019, 'HEPATITIS C VIRUS REINFECTION AFTER SUCCESSFUL TREATMENT WITH DIRECT ACTING ANTIVIRAL THERAPY IN CANADA', in HEPATOLOGY, WILEY, Boston, MA, pp. 183A - 183A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA, 08 November 2019 - 12 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500281&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krajden M; Cook D; Wong S; Wilton J; Butt ZA; Bartlett S; Pearce M; Ramji A; Yoshida EM; Yu A; Alvarez MJ; Binka M; Janjua N, 2019, 'REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT', in HEPATOLOGY, WILEY, Boston, MA, pp. 914A - 914A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA, 08 November 2019 - 12 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653503207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearce M; Samji H; Bartlett S; Wong S; Yu A; Binka M; Alvarez MJ; Butt ZA; Ramji A; Yoshida EM; Krajden M; Janjua N, 2019, 'FACTORS ASSOCIATED WITH HCV TREATMENT INITIATION ACROSS ETHNIC GROUPS IN BRITISH COLUMBIA, CANADA: A POPULATION-BASED COHORT STUDY', in HEPATOLOGY, WILEY, Boston, MA, pp. 345A - 346A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA, 08 November 2019 - 12 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653501115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Darvishian M; Rossi C; Wong S; Yu A; Wong J; Buxton J; Gilbert M; Binka M; Butt Z; Bartlett S; Pearce M; Alvarez M; Cook D; Grennan T; Woods R; Spinelli J; Tyndall M; Krajden M; Janjua N, 2019, 'CANCER RISK AMONG PEOPLE WITH HIV, HBV AND/OR HCV INFECTIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A190 - A191, presented at Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada, http://dx.doi.org/10.1136/sextrans-2019-sti.481

Mckee G; Chapinal N; Butt Z; Rossi C; Wong S; Gilbert M; Wong J; Alvarez M; Darvishian M; Bartlett S; Pearce M; Samji H; Tyndall M; Krajden M; Janjua N, 2019, 'EVOLUTION OF HEPATITIS C CARE CASCADES AMONG HIV AND HEPATITIS B CO-INFECTED PATIENTS IN BRITISH COLUMBIA, CANADA', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A191 - A191, presented at Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada, http://dx.doi.org/10.1136/sextrans-2019-sti.483

Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4